Loading…

Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine

Simian immunodeficiency virus (SIV) infection of macaques is a useful and relevant model for evaluating candidate human immunodeficiency virus (HIV) vaccines. One important feature of this model is that SIV vaccines can be evaluated for their ability to prevent infection as well as to prevent or del...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 1994-07, Vol.170 (1), p.51-59
Main Authors: Hirsch, Vanessa M., Goldstein, Simoy, Hynes, Noreen A., Elkins, William R., London, William T., Zack, Philip M., Montefiori, David, Johnson, Philip R.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c412t-d0a107040cf1fe4c9300b28f37c50c380f01eee7d90f7065a3061f762c9aa6213
cites
container_end_page 59
container_issue 1
container_start_page 51
container_title The Journal of infectious diseases
container_volume 170
creator Hirsch, Vanessa M.
Goldstein, Simoy
Hynes, Noreen A.
Elkins, William R.
London, William T.
Zack, Philip M.
Montefiori, David
Johnson, Philip R.
description Simian immunodeficiency virus (SIV) infection of macaques is a useful and relevant model for evaluating candidate human immunodeficiency virus (HIV) vaccines. One important feature of this model is that SIV vaccines can be evaluated for their ability to prevent infection as well as to prevent or delay the onset of AIDS. In the present study, a group of macaques was vaccinated with whole inactivated SIV and challenged with peripheral blood mononuclear cells from an SIV-infected macaque. This challenge represented a rigorous and realistic test of the immunization protocol. All macaques became infected after challenge; however, immunized animals survived significantly longer (P < .03) than naive controls. These data suggest that similar vaccines administered to humans at risk for HIV-1 infection might delay or prevent AIDS even if the vaccine failed to prevent infection.
doi_str_mv 10.1093/infdis/170.1.51
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_76575467</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30133474</jstor_id><sourcerecordid>30133474</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-d0a107040cf1fe4c9300b28f37c50c380f01eee7d90f7065a3061f762c9aa6213</originalsourceid><addsrcrecordid>eNqFkUFv0zAYhi0EGmVw5oTkA-KW9fvixE6OqGNdpSKGug20i-U5NngkzrCTiv17HFq6406W_bzfI9svIW8RThBqNnfeNi7OUaT9SYnPyAxLJjLOkT0nM4A8z7Cq65fkVYx3AFAwLo7IUQVYlDnMSLwIfdv7H6ahi9Z5p1VL12owXj9Q5Ru6GcPWbdNhb-lnpdXv0US6dFvjqaLffvatoSuv9JAyQ3JsXOeUp6uuG33fGOu0-6e6dmGM9Fpp7bx5TV5Y1UbzZr8ek6uzT5eL82z9ZblafFxnusB8yBpQCAIK0BatKXTNAG7zyjKhS9CsAgtojBFNDVYALxUDjlbwXNdK8RzZMfmw896Hfrr3IDsXtWlb5U0_Ril4KcqCiyeDyDkHqCbjfBfUoY8xGCvvg-tUeJAIcupD7vqQqQ-Jspwm3u3V421nmkN-X0Di7_dcxfT3Niiv0_z_WIFVChWPmrs49OGAGSBjhZh4tuMuDubPgavwS6b3iVKef7-R9c3y68Xp2UbW7C9ke600</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16660081</pqid></control><display><type>article</type><title>Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>Hirsch, Vanessa M. ; Goldstein, Simoy ; Hynes, Noreen A. ; Elkins, William R. ; London, William T. ; Zack, Philip M. ; Montefiori, David ; Johnson, Philip R.</creator><creatorcontrib>Hirsch, Vanessa M. ; Goldstein, Simoy ; Hynes, Noreen A. ; Elkins, William R. ; London, William T. ; Zack, Philip M. ; Montefiori, David ; Johnson, Philip R.</creatorcontrib><description>Simian immunodeficiency virus (SIV) infection of macaques is a useful and relevant model for evaluating candidate human immunodeficiency virus (HIV) vaccines. One important feature of this model is that SIV vaccines can be evaluated for their ability to prevent infection as well as to prevent or delay the onset of AIDS. In the present study, a group of macaques was vaccinated with whole inactivated SIV and challenged with peripheral blood mononuclear cells from an SIV-infected macaque. This challenge represented a rigorous and realistic test of the immunization protocol. All macaques became infected after challenge; however, immunized animals survived significantly longer (P &lt; .03) than naive controls. These data suggest that similar vaccines administered to humans at risk for HIV-1 infection might delay or prevent AIDS even if the vaccine failed to prevent infection.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/170.1.51</identifier><identifier>PMID: 8014520</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>AIDS ; AIDS Vaccines ; AIDS/HIV ; Amino Acid Sequence ; Animals ; Antibodies ; Antibodies, Viral - blood ; Antigens ; Antigens, Viral - blood ; Base Sequence ; Biological and medical sciences ; Blood plasma ; Cells, Cultured ; DNA, Viral ; human immunodeficiency virus ; Humans ; Immunization ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infections ; Lymphocytes ; Macaca ; Macaca nemestrina ; Major Articles ; Medical sciences ; Molecular Sequence Data ; Monocytes - microbiology ; Sequence Homology, Amino Acid ; Simian Acquired Immunodeficiency Syndrome - immunology ; Simian Acquired Immunodeficiency Syndrome - mortality ; Simian Acquired Immunodeficiency Syndrome - physiopathology ; Simian Acquired Immunodeficiency Syndrome - prevention &amp; control ; Simian immunodeficiency virus ; Simian Immunodeficiency Virus - immunology ; Simian Immunodeficiency Virus - physiology ; T-Lymphocyte Subsets - immunology ; Vaccination ; Vaccines, Inactivated - immunology ; Viral Vaccines - immunology ; Virus Latency ; Viruses</subject><ispartof>The Journal of infectious diseases, 1994-07, Vol.170 (1), p.51-59</ispartof><rights>Copyright 1994 The University of Chicago</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-d0a107040cf1fe4c9300b28f37c50c380f01eee7d90f7065a3061f762c9aa6213</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30133474$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30133474$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4182034$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8014520$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hirsch, Vanessa M.</creatorcontrib><creatorcontrib>Goldstein, Simoy</creatorcontrib><creatorcontrib>Hynes, Noreen A.</creatorcontrib><creatorcontrib>Elkins, William R.</creatorcontrib><creatorcontrib>London, William T.</creatorcontrib><creatorcontrib>Zack, Philip M.</creatorcontrib><creatorcontrib>Montefiori, David</creatorcontrib><creatorcontrib>Johnson, Philip R.</creatorcontrib><title>Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>Simian immunodeficiency virus (SIV) infection of macaques is a useful and relevant model for evaluating candidate human immunodeficiency virus (HIV) vaccines. One important feature of this model is that SIV vaccines can be evaluated for their ability to prevent infection as well as to prevent or delay the onset of AIDS. In the present study, a group of macaques was vaccinated with whole inactivated SIV and challenged with peripheral blood mononuclear cells from an SIV-infected macaque. This challenge represented a rigorous and realistic test of the immunization protocol. All macaques became infected after challenge; however, immunized animals survived significantly longer (P &lt; .03) than naive controls. These data suggest that similar vaccines administered to humans at risk for HIV-1 infection might delay or prevent AIDS even if the vaccine failed to prevent infection.</description><subject>AIDS</subject><subject>AIDS Vaccines</subject><subject>AIDS/HIV</subject><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antibodies, Viral - blood</subject><subject>Antigens</subject><subject>Antigens, Viral - blood</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Blood plasma</subject><subject>Cells, Cultured</subject><subject>DNA, Viral</subject><subject>human immunodeficiency virus</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infections</subject><subject>Lymphocytes</subject><subject>Macaca</subject><subject>Macaca nemestrina</subject><subject>Major Articles</subject><subject>Medical sciences</subject><subject>Molecular Sequence Data</subject><subject>Monocytes - microbiology</subject><subject>Sequence Homology, Amino Acid</subject><subject>Simian Acquired Immunodeficiency Syndrome - immunology</subject><subject>Simian Acquired Immunodeficiency Syndrome - mortality</subject><subject>Simian Acquired Immunodeficiency Syndrome - physiopathology</subject><subject>Simian Acquired Immunodeficiency Syndrome - prevention &amp; control</subject><subject>Simian immunodeficiency virus</subject><subject>Simian Immunodeficiency Virus - immunology</subject><subject>Simian Immunodeficiency Virus - physiology</subject><subject>T-Lymphocyte Subsets - immunology</subject><subject>Vaccination</subject><subject>Vaccines, Inactivated - immunology</subject><subject>Viral Vaccines - immunology</subject><subject>Virus Latency</subject><subject>Viruses</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNqFkUFv0zAYhi0EGmVw5oTkA-KW9fvixE6OqGNdpSKGug20i-U5NngkzrCTiv17HFq6406W_bzfI9svIW8RThBqNnfeNi7OUaT9SYnPyAxLJjLOkT0nM4A8z7Cq65fkVYx3AFAwLo7IUQVYlDnMSLwIfdv7H6ahi9Z5p1VL12owXj9Q5Ru6GcPWbdNhb-lnpdXv0US6dFvjqaLffvatoSuv9JAyQ3JsXOeUp6uuG33fGOu0-6e6dmGM9Fpp7bx5TV5Y1UbzZr8ek6uzT5eL82z9ZblafFxnusB8yBpQCAIK0BatKXTNAG7zyjKhS9CsAgtojBFNDVYALxUDjlbwXNdK8RzZMfmw896Hfrr3IDsXtWlb5U0_Ril4KcqCiyeDyDkHqCbjfBfUoY8xGCvvg-tUeJAIcupD7vqQqQ-Jspwm3u3V421nmkN-X0Di7_dcxfT3Niiv0_z_WIFVChWPmrs49OGAGSBjhZh4tuMuDubPgavwS6b3iVKef7-R9c3y68Xp2UbW7C9ke600</recordid><startdate>19940701</startdate><enddate>19940701</enddate><creator>Hirsch, Vanessa M.</creator><creator>Goldstein, Simoy</creator><creator>Hynes, Noreen A.</creator><creator>Elkins, William R.</creator><creator>London, William T.</creator><creator>Zack, Philip M.</creator><creator>Montefiori, David</creator><creator>Johnson, Philip R.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19940701</creationdate><title>Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine</title><author>Hirsch, Vanessa M. ; Goldstein, Simoy ; Hynes, Noreen A. ; Elkins, William R. ; London, William T. ; Zack, Philip M. ; Montefiori, David ; Johnson, Philip R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-d0a107040cf1fe4c9300b28f37c50c380f01eee7d90f7065a3061f762c9aa6213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>AIDS</topic><topic>AIDS Vaccines</topic><topic>AIDS/HIV</topic><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antibodies, Viral - blood</topic><topic>Antigens</topic><topic>Antigens, Viral - blood</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Blood plasma</topic><topic>Cells, Cultured</topic><topic>DNA, Viral</topic><topic>human immunodeficiency virus</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infections</topic><topic>Lymphocytes</topic><topic>Macaca</topic><topic>Macaca nemestrina</topic><topic>Major Articles</topic><topic>Medical sciences</topic><topic>Molecular Sequence Data</topic><topic>Monocytes - microbiology</topic><topic>Sequence Homology, Amino Acid</topic><topic>Simian Acquired Immunodeficiency Syndrome - immunology</topic><topic>Simian Acquired Immunodeficiency Syndrome - mortality</topic><topic>Simian Acquired Immunodeficiency Syndrome - physiopathology</topic><topic>Simian Acquired Immunodeficiency Syndrome - prevention &amp; control</topic><topic>Simian immunodeficiency virus</topic><topic>Simian Immunodeficiency Virus - immunology</topic><topic>Simian Immunodeficiency Virus - physiology</topic><topic>T-Lymphocyte Subsets - immunology</topic><topic>Vaccination</topic><topic>Vaccines, Inactivated - immunology</topic><topic>Viral Vaccines - immunology</topic><topic>Virus Latency</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hirsch, Vanessa M.</creatorcontrib><creatorcontrib>Goldstein, Simoy</creatorcontrib><creatorcontrib>Hynes, Noreen A.</creatorcontrib><creatorcontrib>Elkins, William R.</creatorcontrib><creatorcontrib>London, William T.</creatorcontrib><creatorcontrib>Zack, Philip M.</creatorcontrib><creatorcontrib>Montefiori, David</creatorcontrib><creatorcontrib>Johnson, Philip R.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hirsch, Vanessa M.</au><au>Goldstein, Simoy</au><au>Hynes, Noreen A.</au><au>Elkins, William R.</au><au>London, William T.</au><au>Zack, Philip M.</au><au>Montefiori, David</au><au>Johnson, Philip R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1994-07-01</date><risdate>1994</risdate><volume>170</volume><issue>1</issue><spage>51</spage><epage>59</epage><pages>51-59</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>Simian immunodeficiency virus (SIV) infection of macaques is a useful and relevant model for evaluating candidate human immunodeficiency virus (HIV) vaccines. One important feature of this model is that SIV vaccines can be evaluated for their ability to prevent infection as well as to prevent or delay the onset of AIDS. In the present study, a group of macaques was vaccinated with whole inactivated SIV and challenged with peripheral blood mononuclear cells from an SIV-infected macaque. This challenge represented a rigorous and realistic test of the immunization protocol. All macaques became infected after challenge; however, immunized animals survived significantly longer (P &lt; .03) than naive controls. These data suggest that similar vaccines administered to humans at risk for HIV-1 infection might delay or prevent AIDS even if the vaccine failed to prevent infection.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>8014520</pmid><doi>10.1093/infdis/170.1.51</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1994-07, Vol.170 (1), p.51-59
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_76575467
source JSTOR Archival Journals and Primary Sources Collection; Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025
subjects AIDS
AIDS Vaccines
AIDS/HIV
Amino Acid Sequence
Animals
Antibodies
Antibodies, Viral - blood
Antigens
Antigens, Viral - blood
Base Sequence
Biological and medical sciences
Blood plasma
Cells, Cultured
DNA, Viral
human immunodeficiency virus
Humans
Immunization
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Infections
Lymphocytes
Macaca
Macaca nemestrina
Major Articles
Medical sciences
Molecular Sequence Data
Monocytes - microbiology
Sequence Homology, Amino Acid
Simian Acquired Immunodeficiency Syndrome - immunology
Simian Acquired Immunodeficiency Syndrome - mortality
Simian Acquired Immunodeficiency Syndrome - physiopathology
Simian Acquired Immunodeficiency Syndrome - prevention & control
Simian immunodeficiency virus
Simian Immunodeficiency Virus - immunology
Simian Immunodeficiency Virus - physiology
T-Lymphocyte Subsets - immunology
Vaccination
Vaccines, Inactivated - immunology
Viral Vaccines - immunology
Virus Latency
Viruses
title Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T19%3A53%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolonged%20Clinical%20Latency%20and%20Survival%20of%20Macaques%20Given%20a%20Whole%20Inactivated%20Simian%20Immunodeficiency%20Virus%20Vaccine&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Hirsch,%20Vanessa%20M.&rft.date=1994-07-01&rft.volume=170&rft.issue=1&rft.spage=51&rft.epage=59&rft.pages=51-59&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/170.1.51&rft_dat=%3Cjstor_proqu%3E30133474%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-d0a107040cf1fe4c9300b28f37c50c380f01eee7d90f7065a3061f762c9aa6213%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16660081&rft_id=info:pmid/8014520&rft_jstor_id=30133474&rfr_iscdi=true